Literature DB >> 22829630

Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells.

Kurtis J Haro1, Andrew C Scott, David A Scheinberg.   

Abstract

Low linear energy transfer (LET) ionizing radiation (IR) is an important form of therapy for acute leukemias administered externally or as radioimmunotherapy. IR is also a potential source of DNA damage. High LET IR produces structurally different forms of DNA damage and has emerged as potential treatment of metastatic and hematopoietic malignancies. Therefore, understanding mechanisms of resistance is valuable. We created stable myeloid leukemia HL60 cell clones radioresistant to either γ-rays or α-particles to understand possible mechanisms in radioresistance. Cross-resistance to each type of IR was observed, but resistance to clustered, complex α-particle damage was substantially lower than to equivalent doses of γ-rays. The resistant phenotype was driven by changes in: apoptosis; late G2/M checkpoint accumulation that was indicative of increased genomic instability; stronger dependence on homology-directed repair; and more robust repair of DNA double-strand breaks and sublethal-type damage induced by γ-rays, but not by α-particles. The more potent cytotoxicity of α-particles warrants their continued investigation as therapies for leukemia and other cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829630      PMCID: PMC3437596          DOI: 10.1182/blood-2012-01-404509

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Variations in several responses of HeLa cells to x-irradiation during the division cycle.

Authors:  T TERASIMA; L J TOLMACH
Journal:  Biophys J       Date:  1963-01       Impact factor: 4.033

Review 2.  Importance of the cell cycle phase for the choice of the appropriate DSB repair pathway, for genome stability maintenance: the trans-S double-strand break repair model.

Authors:  Fabien Delacôte; Bernard S Lopez
Journal:  Cell Cycle       Date:  2007-10-03       Impact factor: 4.534

3.  Unrepaired clustered DNA lesions induce chromosome breakage in human cells.

Authors:  Aroumougame Asaithamby; Burong Hu; David J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-28       Impact factor: 11.205

4.  Exposure to fractionated dose of 60 Gy affects molecular response of HL-60 cells to irradiation.

Authors:  Jiřina Vávrová; Aleš Tichý; Martina Rezáčová; Lenka Zárybnická; Zuzana Sinkorová; Jan Osterreicher
Journal:  Gen Physiol Biophys       Date:  2010-09       Impact factor: 1.512

5.  Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells.

Authors:  Claudia Friesen; Gerhard Glatting; Bernd Koop; Klaus Schwarz; Alfred Morgenstern; Christos Apostolidis; Klaus-Michael Debatin; Sven N Reske
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

6.  Oxidation of the sugar moiety of DNA by ionizing radiation or bleomycin could induce the formation of a cluster DNA lesion.

Authors:  Peggy Regulus; Benoit Duroux; Pierre-Alain Bayle; Alain Favier; Jean Cadet; Jean-Luc Ravanat
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

7.  Kinetics and dose-response of residual 53BP1/gamma-H2AX foci: co-localization, relationship with DSB repair and clonogenic survival.

Authors:  E Marková; N Schultz; I Y Belyaev
Journal:  Int J Radiat Biol       Date:  2007-05       Impact factor: 2.694

8.  Relative sensitivities of repair-deficient mammalian cells for clonogenic survival after alpha-particle irradiation.

Authors:  Mark A Hill; M Trent Herdman; David L Stevens; Nigel J Jones; John Thacker; Dudley T Goodhead
Journal:  Radiat Res       Date:  2004-12       Impact factor: 2.841

Review 9.  An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cells.

Authors:  Andrea Krempler; Dorothee Deckbar; Penny A Jeggo; Markus Löbrich
Journal:  Cell Cycle       Date:  2007-05-21       Impact factor: 4.534

10.  Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.

Authors:  Sten Nilsson; Lars Franzén; Christopher Parker; Christopher Tyrrell; René Blom; Jan Tennvall; Bo Lennernäs; Ulf Petersson; Dag C Johannessen; Michael Sokal; Katharine Pigott; Jeffrey Yachnin; Michael Garkavij; Peter Strang; Johan Harmenberg; Bjørg Bolstad; Oyvind S Bruland
Journal:  Lancet Oncol       Date:  2007-07       Impact factor: 41.316

View more
  15 in total

Review 1.  Molecular pathways: targeted α-particle radiation therapy.

Authors:  Kwamena E Baidoo; Kwon Yong; Martin W Brechbiel
Journal:  Clin Cancer Res       Date:  2012-12-10       Impact factor: 12.531

2.  Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy.

Authors:  Alireza Karimian; Nathan T Ji; Hong Song; George Sgouros
Journal:  Cancer Res       Date:  2019-11-26       Impact factor: 12.701

3.  The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model.

Authors:  Shyril O'Steen; Melissa L Comstock; Johnnie J Orozco; Donald K Hamlin; D Scott Wilbur; Jon C Jones; Aimee Kenoyer; Margaret E Nartea; Yukang Lin; Brian W Miller; Theodore A Gooley; Sherilyn A Tuazon; Brian G Till; Ajay K Gopal; Brenda M Sandmaier; Oliver W Press; Damian J Green
Journal:  Blood       Date:  2019-10-10       Impact factor: 22.113

4.  Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.

Authors:  Sergey Iordanskiy; Rachel Van Duyne; Gavin C Sampey; Caitlin M Woodson; Kelsi Fry; Mohammed Saifuddin; Jia Guo; Yuntao Wu; Fabio Romerio; Fatah Kashanchi
Journal:  Virology       Date:  2015-07-14       Impact factor: 3.616

5.  Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.

Authors:  Chuanhao Zhang; Dong Zhou; Zhe Wang; Zaishuang Ju; Jiabei He; Genghao Zhao; Ruoyu Wang
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 6.  Advances in the treatment of hematologic malignancies using immunoconjugates.

Authors:  Maria Corinna Palanca-Wessels; Oliver W Press
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

Review 7.  Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.

Authors:  George Sgouros
Journal:  Semin Nucl Med       Date:  2020-02-26       Impact factor: 4.446

8.  A radioresistant fraction of acute promyelocytic leukemia cells exhibit CD38 cell-surface antigen and mRNA expression.

Authors:  Satoru Monzen; Mitsuru Chiba; Tatsuya Ueno; Yuki Morino; Kenji Terada; Hiroki Yamaya; Yoichiro Hosokawa
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

9.  Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation.

Authors:  Brian D Yard; Priyanka Gopal; Kristina Bannik; Gerhard Siemeister; Urs B Hagemann; Mohamed E Abazeed
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

10.  Why bother with alpha particles?

Authors:  A Paden King; Frank I Lin; Freddy E Escorcia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.